If you are having trouble viewing this message, please Click Here
 |
| |
Today is: April 14, 2011
|
THIS e-Newsletter is reaching people in (83) Countries |
ENJOY OUR NEW LOOK and Tell us what you think... TOPICS this week include: MORE on the ORAL MEDICATIONS, CCSVI Update, Cooling Vests, Information on Hot Weather, This week's podcast, Pharmaceutical Resources, Social Media, Learning Videos and more.... ~~~~~~~~~~~~~~~~~~~~~~~~~~ |
|
"Providing You with
'MS Views and News', IS What We Do" _______________________________ |
|
WE are a NOT for Profit
MSV&N is a 501©(3) organization as recognized by the Internal Revenue Service. Your gift is tax deductible to the extent permitted by law.
. |
$$ DONATIONS PLEASE $$ Every Dollar Counts
Please click here
All Contibutions are Tax Deductible
|
|
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
UPDATED News and Information
Biogen Idec’s oral multiple sclerosis candidate, BG-12 (dimethyl fumarate), met its primary endpoint in the first of two Phase III pivotal trials in patients with relapsing-remitting disease Apr 13, 2011
Multiple Sclerosis Cooling Program Apr 13, 2011
New Copaxone® data reported from AAN demonstrate clinical benefits of switching MS patients to Copaxone®. Apr 13, 2011
Potential New MS PIll: Experimental medication slowed the rate of brain atrophy and disease progression and relapse, study found Apr 13, 2011
MULTIPLE SCLEROSIS & other DIFF. ABILITIES Apr 13, 2011
Biogen Idec's Ongoing Dedication To People Living With MS Apr 12, 2011
Oral Laquinimod For MS Treatment Significantly Reduced Disease Activity And Disability Progression While Providing Good Safety And Tolerability Apr 12, 2011
Mayo Clinic Finds Tool To Predict Disability Timeline For Progressive MS Patients Apr 12, 2011
"Laughter is the Best Medicine" - a Two Night performance on Long Island (NY) to benefit MS education Apr 12, 2011
Biogen Oral MS Pill Meets Goals of Study Apr 11, 2011
Media Release: Novartis therapy GilenyaTM reduced the risk of MS disability progression regardless of disease severity Apr 11, 2011
Laquinimod, Alemtuzumab, CCSVI, and much more, to be discussed at the AAN meeting in Hawaii, April 9th thru 16th Apr 08, 2011
Tysabri Label Modified to Include More Brain Infection Data Apr 08, 2011
CCSVI update: Saskatchewan and Manitoba partner on liberation treatment Apr 08, 2011
More evidence pregnancy is safe with MS Apr 08, 2011
Warm or ever Hot weather - and how it can affect the MS patient Apr 08, 2011
Pediatric MS: Self-Advocacy and the Healthcare Team Apr 08, 2011
Cerebrospinal Venous Angioplasty Safe in MS as per the Society of Interventional Radiology Apr 06, 2011
RSVP's needed for an MS education Program in Melbourne, Fl. - “New and Emerging Therapies Brings Quality of Life to those affected by Multiple Sclerosis” Apr 06, 2011
THIS WEEKS PODCAST: http://www.youtube.com/watch?v=GvsXWMeXwMo
=============================================================
www.tysabri.com
=============================================================
SOCIAL MEDIA and Other Learning Methods
============================================================ WATCH our archived Podcasts (webcasts) ``````````````````````````````````` Visit our Online Charity Auctions regularly, and please bid. We always have a lot of wonderful things up for sale. Maybe you will find something for yourself or, perhaps, a gift for someone else. ```````````````````````````````````````````` Scroll to the bottom of the blog-page to see all the videos found there, for you to learn from. Come back to see us next week and please tell others of our new easy to read look |
| |
| ==================== Visit Our Blog, Bookmark the website and review each week's informational M.S. postings by Clicking here ================== SHARE OUR WEBSITE and BLOG Facebook and Twitter information and Website addresses (URL's) WITH OTHERS ================ TIME and Effort are put into each week's e-newsletters and podcast series. Please share the information we provide to educate and inform, with others. |
|
| Sponsorships for this e-Newsletter and our podcast series, are provided by: ================================ |
|
|
OUR MISSION: 'MS Views and News' (MSVN) is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis. In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS.
-Newsletter Disclaimer:
***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
|
|
|
No comments:
Post a Comment
Leave comments only that directly pertain to each article.
All solicitations will be removed.